Apoptosis therapy: driving cancers down the road to ruin
- PMID: 23389605
- DOI: 10.1038/nm.3076
Apoptosis therapy: driving cancers down the road to ruin
Comment on
-
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6. Nat Med. 2013. PMID: 23291630
Similar articles
-
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.Nat Med. 2013 Feb;19(2):202-8. doi: 10.1038/nm.3048. Epub 2013 Jan 6. Nat Med. 2013. PMID: 23291630
-
Pioneering apoptosis-targeted cancer drug poised for FDA approval.Nat Rev Drug Discov. 2016 Mar;15(3):147-9. doi: 10.1038/nrd.2016.23. Nat Rev Drug Discov. 2016. PMID: 26931080 No abstract available.
-
Forecast: rough seas for leukemia.Cancer Discov. 2014 Mar;4(3):278-9. doi: 10.1158/2159-8290.CD-14-0084. Cancer Discov. 2014. PMID: 24596202
-
Venetoclax: First Global Approval.Drugs. 2016 Jun;76(9):979-87. doi: 10.1007/s40265-016-0596-x. Drugs. 2016. PMID: 27260335 Review.
-
Venetoclax: Targeting BCL2 in Hematological Cancers.Recent Results Cancer Res. 2018;212:215-242. doi: 10.1007/978-3-319-91439-8_11. Recent Results Cancer Res. 2018. PMID: 30069633 Review.
Cited by
-
Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells.Oncogene. 2017 Mar 30;36(13):1849-1861. doi: 10.1038/onc.2016.348. Epub 2016 Oct 17. Oncogene. 2017. PMID: 27748762 Free PMC article.
-
Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.Cell Death Dis. 2020 Oct 17;11(10):875. doi: 10.1038/s41419-020-03092-7. Cell Death Dis. 2020. PMID: 33070156 Free PMC article.
-
Novel agents in follicular lymphoma: choosing the best target.Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):284-292. doi: 10.1182/asheducation-2016.1.284. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913493 Free PMC article. Review.
-
Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs.Front Pharmacol. 2019 Feb 19;10:55. doi: 10.3389/fphar.2019.00055. eCollection 2019. Front Pharmacol. 2019. PMID: 30886578 Free PMC article. Review.
-
Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins.Oncotarget. 2014 Sep 30;5(18):8452-65. doi: 10.18632/oncotarget.2320. Oncotarget. 2014. PMID: 25115399 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources